GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Organon Pharma Indonesia PT (ISX:SCPI) » Definitions » ROA %

Organon Pharma Indonesia PT (ISX:SCPI) ROA % : 0.00% (As of . 20)


View and export this data going back to 1990. Start your Free Trial

What is Organon Pharma Indonesia PT ROA %?

ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. Organon Pharma Indonesia PT's annualized Net Income for the quarter that ended in . 20 was Rp Mil. Organon Pharma Indonesia PT's average Total Assets over the quarter that ended in . 20 was Rp 0 Mil. Therefore, Organon Pharma Indonesia PT's annualized ROA % for the quarter that ended in . 20 was Not Available.

The historical rank and industry rank for Organon Pharma Indonesia PT's ROA % or its related term are showing as below:

ISX:SCPI's ROA % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 1.705
* Ranked among companies with meaningful ROA % only.

Organon Pharma Indonesia PT ROA % Historical Data

The historical data trend for Organon Pharma Indonesia PT's ROA % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Organon Pharma Indonesia PT ROA % Chart

Organon Pharma Indonesia PT Annual Data
Trend
ROA %

Organon Pharma Indonesia PT Quarterly Data
ROA %

Competitive Comparison of Organon Pharma Indonesia PT's ROA %

For the Drug Manufacturers - Specialty & Generic subindustry, Organon Pharma Indonesia PT's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Organon Pharma Indonesia PT's ROA % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Organon Pharma Indonesia PT's ROA % distribution charts can be found below:

* The bar in red indicates where Organon Pharma Indonesia PT's ROA % falls into.



Organon Pharma Indonesia PT ROA % Calculation

Organon Pharma Indonesia PT's annualized ROA % for the fiscal year that ended in . 20 is calculated as:

ROA %=Net Income (A: . 20 )/( (Total Assets (A: . 20 )+Total Assets (A: . 20 ))/ count )
=/( (+)/ )
=/
= %

Organon Pharma Indonesia PT's annualized ROA % for the quarter that ended in . 20 is calculated as:

ROA %=Net Income (Q: . 20 )/( (Total Assets (Q: . 20 )+Total Assets (Q: . 20 ))/ count )
=/( (+)/ )
=/
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is four times the quarterly (. 20) net income data. ROA % is displayed in the 30-year financial page.


Organon Pharma Indonesia PT  (ISX:SCPI) ROA % Explanation

ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A bank’s ROA % is typically well under 2%.

Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:

Note: The Net Income data used here is four times the quarterly (. 20) net income data. The Revenue data used here is four times the quarterly (. 20) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.

E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.


Organon Pharma Indonesia PT ROA % Related Terms

Thank you for viewing the detailed overview of Organon Pharma Indonesia PT's ROA % provided by GuruFocus.com. Please click on the following links to see related term pages.


Organon Pharma Indonesia PT (ISX:SCPI) Business Description

Traded in Other Exchanges
N/A
Address
Jalan Jend Sudirman Kav 21, Sinarmas MSIG Tower, Floor 37 Unit 102 & 106, South Jakarta, IDN, 12920
Organon Pharma Indonesia PT engages in the development, manufacture, and distribution of pharmaceutical products. It operates through manufacturing and commercial segments. Manufacturing, which generates the majority of the revenue, is engaged in pharmaceutical manufacturing.

Organon Pharma Indonesia PT (ISX:SCPI) Headlines

No Headlines